Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
---|---|---|---|---|
Total reported revenue | 13.3B | 13.2B | 14.5B | 15.1B |
Cost of revenue | 11.2B | 11.8B | 11.3B | 11.9B |
Gross profit | 2.1B | 1.4B | 3.2B | 3.2B |
Operating expense | ||||
Research & development | — | — | — | — |
Selling general and admin | — | — | — | — |
Other operating expenses | 839.2M | 361.4M | 174.3M | 301.7M |
Operating income | 1.2B | 1.0B | 3.0B | 2.9B |
Non operating interest income | ||||
Income | — | — | — | — |
Expense | 388.1M | 639.2M | 432M | 404M |
Other income expense | — | — | — | — |
Pretax income | 1.7B | 837.3M | 3.0B | 3.0B |
Tax provision | -138M | 82.1M | 69.8M | 68.2M |
Net income | 1.9B | 755.2M | 2.9B | 2.9B |
Basic EPS | — | 1.6 | 6.3 | 6.3 |
Diluted EPS | — | 1.6 | 6.3 | 6.3 |
Basic average shares | — | 466.2M | 465.6M | 465.6M |
Diluted average shares | — | 466.2M | 465.6M | 465.6M |
EBITDA | 2.1B | 1.5B | 3.4B | 3.4B |
Net income from continuing op. | — | — | — | — |
Minority interests | — | — | — | — |
Preferred stock dividends | 0 | 0 | 0 | 0 |